Biogen (BIIB) Financial Forecast Calculator
Interactive 5-year forecast and DCF for Biogen. Adjust revenue growth, gross margin, capex intensity, WACC, and terminal growth - see revenue, free cash flow, and enterprise value update in real time. Seeded from Biogen’s most recent SEC filings.
Assumptions
Need this as an Excel model?
Keep iterating on the Biogen forecast in Excel. The downloadable sample has every assumption you see here plus a fully integrated income statement, balance sheet, cash flow, and debt schedule - five years of SEC historicals and live formulas in a fully editable workbook.
Other Healthcare forecasts
Run the same calculator on a peer.
Frequently asked
What is Biogen's primary business focus?+
Biogen Inc. is a global biotechnology company dedicated to discovering, developing, and delivering therapies for neurological, immunological, and rare diseases. The company is strategically shifting from its historical reliance on multiple sclerosis treatments towards a new portfolio of growth products.
How does Biogen generate its revenue?+
Biogen generates revenue primarily from product sales, including its legacy MS franchise and new rare disease products, which constitute about 72% of its total revenue. Additional revenue streams include royalties from Anti-CD20 Therapeutic Programs, profits from Alzheimer's collaboration, and contract manufacturing services.
What is the projected revenue growth rate for Biogen in the financial model?+
The financial model for Biogen assumes a revenue growth rate of approximately -9.06%. This reflects the company's strategic pivot and the structural decline of its legacy multiple sclerosis franchise.
What is Biogen's typical capital expenditure as a percentage of revenue?+
Biogen's capital expenditure as a percentage of revenue is very low, typically ranging from 1.5% to 2.0%. The financial model uses a Capex_Pct_Revenue assumption of approximately 2.85%.
What is the main purpose of the Biogen financial model?+
The Biogen financial model aims to evaluate whether the company's rapidly scaling growth products can generate sufficient cash flow to offset the decline of its legacy multiple sclerosis franchise. Ultimately, it assesses the company's equity valuation and its capacity for future pipeline-expanding acquisitions.
Can I download an Excel financial model for Biogen?+
Yes, a downloadable Excel financial model is available for Biogen. This general corporate model provides a forecast horizon from FY2026 to FY2030.
Have more financial modelling questions? Contact us
